Search Results

Viral Delivery of Compact CRISPR-Cas12f for Gene Editing Applications.

• Authors : Sharrar A; Acrigen Biosciences Inc., Berkeley, California, USA.; Meacham Z

• Source: The CRISPR journal [CRISPR J] 2024 May 02. Date of Electronic Publication: 2024 May 02.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101738191 Publication Model: Print-Electronic

Record details

An Undergraduate Course in CRISPR/Cas9-Mediated Gene Editing in Zebrafish.

• Authors : Srivastava R; Department of Genetics, Development and Cell Biology, Iowa State University, Ames, Iowa, USA.; Davison CW

Subjects: Gene Editing*/Gene Editing*/Gene Editing*/methods ; CRISPR-Cas Systems*; Humans

• Source: Zebrafish [Zebrafish] 2024 Apr; Vol. 21 (2), pp. 162-170.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101225070 Publication Model: Print Cited

Record details

Gene Editing in the Chagas Disease Vector Rhodnius prolixus by Cas9-Mediated ReMOT Control.

• Authors : Lima L; Program in Cell and Developmental Biology, Institute for Biomedical Sciences, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil, Rio de Janeiro, Brazil.; Berni M

Subjects: Rhodnius*/Rhodnius*/Rhodnius*/genetics ; Rhodnius*/Rhodnius*/Rhodnius*/parasitology ; Chagas Disease*/Chagas Disease*/Chagas Disease*/genetics

• Source: The CRISPR journal [CRISPR J] 2024 Apr; Vol. 7 (2), pp. 88-99. Date of Electronic Publication: 2024 Apr 01.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101738191 Publication Model: Print-Electronic

Record details

Trichostatin A for Efficient CRISPR-Cas9 Gene Editing of Human Pluripotent Stem Cells.

• Authors : Molugu K; Biophysics Graduate Program, University of Wisconsin-Madison, Madison, Wisconsin, USA; St Jude Children's Research Hospital, Memphis, Tennessee, USA.

Subjects: Gene Editing*/Gene Editing*/Gene Editing*/methods ; Induced Pluripotent Stem Cells*; Humans

• Source: The CRISPR journal [CRISPR J] 2023 Oct; Vol. 6 (5), pp. 473-485. Date of Electronic Publication: 2023 Sep 07.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101738191 Publication Model: Print-Electronic

Record details

Novel CRISPR-Associated Gene-Editing Systems Discovered in Metagenomic Samples Enable Efficient and Specific Genome Engineering.

• Authors : Lamothe RC; Metagenomi, Inc., Emeryville, California, USA.; Storlie MD

Subjects: Gene Editing* ; CRISPR-Cas Systems*/CRISPR-Cas Systems*/CRISPR-Cas Systems*/genetics; Humans

• Source: The CRISPR journal [CRISPR J] 2023 Jun; Vol. 6 (3), pp. 243-260. Date of Electronic Publication: 2023 May 23.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101738191 Publication Model: Print-Electronic

Record details

T Cell Nrf2/Keap1 Gene Editing Using CRISPR/Cas9 and Experimental Kidney Ischemia-Reperfusion Injury.

• Authors : Kurzhagen JT; Division of Nephrology and Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Noel S

Subjects: Antioxidants*/Antioxidants*/Antioxidants*/metabolism ; Reperfusion Injury*/Reperfusion Injury*/Reperfusion Injury*/genetics ; Reperfusion Injury*/Reperfusion Injury*/Reperfusion Injury*/therapy

• Source: Antioxidants & redox signaling [Antioxid Redox Signal] 2023 May; Vol. 38 (13-15), pp. 959-973. Date of Electronic Publication: 2023 Mar 16.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 100888899 Publication Model: Print-Electronic

Record details

Gene Editing Corrects In Vitro a G > A GLB1 Transition from a GM1 Gangliosidosis Patient.

• Authors : Leclerc D; INSERM U1242, OSS, Univ Rennes, Rennes, France.; Goujon L

Subjects: Gangliosidosis, GM1*/Gangliosidosis, GM1*/Gangliosidosis, GM1*/therapy ; Gangliosidosis, GM1*/Gangliosidosis, GM1*/Gangliosidosis, GM1*/drug therapy; Humans

• Source: The CRISPR journal [CRISPR J] 2023 Feb; Vol. 6 (1), pp. 17-31. Date of Electronic Publication: 2023 Jan 11.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101738191 Publication Model: Print-Electronic

Record details

Optimized Guide RNA Selection Improves Streptococcus pyogenes Cas9 Gene Editing of Human Hematopoietic Stem and Progenitor Cells.

• Authors : Verhagen HJMP; Department of Hematopoiesis and Sanquin Research, Landsteiner Laboratory, Department of Molecular Hematology, Amsterdam UMC, University of Amsterdam, The Netherlands.; Kuijk C

Subjects: Gene Editing*/Gene Editing*/Gene Editing*/methods; Humans ; CRISPR-Cas Systems/CRISPR-Cas Systems/CRISPR-Cas Systems/genetics

• Source: The CRISPR journal [CRISPR J] 2022 Oct; Vol. 5 (5), pp. 702-716. Date of Electronic Publication: 2022 Sep 28.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101738191 Publication Model: Print-Electronic

Record details

Gene Editing and Rett Syndrome: Does It Make the Cut?

• Authors : Coorey B; Faculty of Medicine and Health, School of Medical Sciences, The University of Sydney, Sydney, Australia; Military Institute of Medicine, Warsaw, Poland.

Subjects: Rett Syndrome*/Rett Syndrome*/Rett Syndrome*/genetics ; Rett Syndrome*/Rett Syndrome*/Rett Syndrome*/metabolism ; Rett Syndrome*/Rett Syndrome*/Rett Syndrome*/therapy

• Source: The CRISPR journal [CRISPR J] 2022 Aug; Vol. 5 (4), pp. 490-499. Date of Electronic Publication: 2022 Jul 26.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101738191 Publication Model: Print-Electronic

Record details

Electroporation-Mediated Delivery of Cas9 Ribonucleoproteins Results in High Levels of Gene Editing in Primary Hepatocytes.

• Authors : Rathbone T; Department of Bioengineering, University College Cork, Cork, Ireland.; Ates I

Subjects: Gene Editing*/Gene Editing*/Gene Editing*/methods ; Ribonucleoproteins*/Ribonucleoproteins*/Ribonucleoproteins*/genetics ; Ribonucleoproteins*/Ribonucleoproteins*/Ribonucleoproteins*/metabolism

• Source: The CRISPR journal [CRISPR J] 2022 Jun; Vol. 5 (3), pp. 397-409. Date of Electronic Publication: 2022 Mar 02.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101738191 Publication Model: Print-Electronic

Record details

Efficient and Fast Generation of Relevant Disease Mouse Models by In Vitro and In Vivo Gene Editing of Zygotes.

• Authors : Sanchez-Baltasar R; Molecular and Translational Oncology Division, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), Madrid, Spain.; Instituto de Investigación Sanitaria Hospital 12 de octubre (imas12), Madrid, Spain.

Subjects: Gene Editing*/Gene Editing*/Gene Editing*/methods ; Zygote*/Zygote*/Zygote*/metabolism; Animals

• Source: The CRISPR journal [CRISPR J] 2022 Jun; Vol. 5 (3), pp. 422-434.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101738191 Publication Model: Print Cited

Record details

Gene Editing of Checkpoint Molecules in Cord Blood-Derived Dendritic Cells and CD8 + T Cells Using CRISPR-Cas9.

• Authors : Lo Presti V; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Center for Translational Immunology, UMC Utrecht, Utrecht, The Netherlands.

Subjects: Gene Editing*/Gene Editing*/Gene Editing*/methods ; Neoplasms*/Neoplasms*/Neoplasms*/genetics; CD8-Positive T-Lymphocytes

• Source: The CRISPR journal [CRISPR J] 2022 Jun; Vol. 5 (3), pp. 435-444.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101738191 Publication Model: Print Cited

Record details

Evolutionary Biology and Gene Editing of Cat Allergen, Fel d 1.

• Authors : Brackett NF; InBio, Charlottesville, Virginia, USA; Department of Obstetrics and Gynecology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.

Subjects: Allergens*/Allergens*/Allergens*/chemistry ; Allergens*/Allergens*/Allergens*/genetics ; Hypersensitivity*/Hypersensitivity*/Hypersensitivity*/genetics

• Source: The CRISPR journal [CRISPR J] 2022 Apr; Vol. 5 (2), pp. 213-223. Date of Electronic Publication: 2022 Mar 28.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101738191 Publication Model: Print-Electronic

Record details

Bacterial Retrons Enable Precise Gene Editing in Human Cells.

• Authors : Zhao B; Department of Biology, Stanford University, Stanford, California, USA.; Chen SA

Subjects: Gene Editing* ; RNA-Directed DNA Polymerase*/RNA-Directed DNA Polymerase*/RNA-Directed DNA Polymerase*/genetics ; RNA-Directed DNA Polymerase*/RNA-Directed DNA Polymerase*/RNA-Directed DNA Polymerase*/metabolism

• Source: The CRISPR journal [CRISPR J] 2022 Feb; Vol. 5 (1), pp. 31-39. Date of Electronic Publication: 2022 Jan 24.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101738191 Publication Model: Print-Electronic

Record details

CRISPR-Cas9 Gene Editing Protects from the A53T-SNCA Overexpression-Induced Pathology of Parkinson's Disease In Vivo .

• Authors : Yoon HH; Department of Neurological Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea; Kyung Hee University, Seoul, Korea.

Subjects: Gene Editing* ; Parkinson Disease*/Parkinson Disease*/Parkinson Disease*/genetics ; Parkinson Disease*/Parkinson Disease*/Parkinson Disease*/metabolism

• Source: The CRISPR journal [CRISPR J] 2022 Feb; Vol. 5 (1), pp. 95-108.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101738191 Publication Model: Print Cited

Record details

Genetically Encoded CRISPR Components Yield Efficient Gene Editing in the Invasive Pest Drosophila suzukii .

• Authors : Kandul NP; Division of Biological Sciences, Section of Cell and Developmental Biology, University of California, San Diego, La Jolla, California, USA; and North Carolina State University, Raleigh, North Carolina, USA.

Subjects: CRISPR-Cas Systems*; Drosophila/Drosophila/Drosophila/*genetics ; Gene Editing/Gene Editing/Gene Editing/*methods

• Source: The CRISPR journal [CRISPR J] 2021 Oct; Vol. 4 (5), pp. 739-751.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101738191 Publication Model: Print Cited

Record details

Learning from the Past: Discussing Lessons from Reproductive Justice in the Gene-Editing Sphere.

• Authors : Philippe-Auguste J; Wellesley College, Wellesley, Massachusetts, USA.; Berdecio I

Subjects: Vulnerable Populations*; Eugenics/Eugenics/Eugenics/*methods ; Gene Editing/Gene Editing/Gene Editing/*ethics

• Source: Genetic testing and molecular biomarkers [Genet Test Mol Biomarkers] 2021 Sep; Vol. 25 (9), pp. 571-572.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101494210 Publication Model: Print Cited

Record details

Increasing Gene Editing Efficiency for CRISPR-Cas9 by Small RNAs in Pluripotent Stem Cells.

• Authors : Shahryari A; Institute of Diabetes and Regeneration Research, Helmholtz Zentrum München, Neuherberg, Germany; Golestan University of Medical Sciences, Gorgan, Iran.

Subjects: CRISPR-Cas Systems* ; Gene Editing*/Gene Editing*/Gene Editing*/methods ; Gene Expression*

• Source: The CRISPR journal [CRISPR J] 2021 Aug; Vol. 4 (4), pp. 491-501.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101738191 Publication Model: Print Cited

Record details

The View from the Benches: Scientists' Perspectives on the Uses and Governance of Human Gene-Editing Research.

• Authors : Waltz M; Department of Social Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA; Chapel Hill, North Carolina, USA.

Subjects: Attitude of Health Personnel* ; Gene Editing* ; Research*

• Source: The CRISPR journal [CRISPR J] 2021 Aug; Vol. 4 (4), pp. 609-615.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101738191 Publication Model: Print Cited

Record details

A Decade of CRISPR Gene Editing in China and Beyond: A Scientometric Landscape.

• Authors : Zhou W; Zhejiang Academy of Science and Technology Information, Hangzhou, China; and Hangzhou, China.

Subjects: CRISPR-Cas Systems*; Gene Editing/Gene Editing/Gene Editing/*history ; Gene Editing/Gene Editing/Gene Editing/*trends

• Source: The CRISPR journal [CRISPR J] 2021 Jun; Vol. 4 (3), pp. 313-320.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101738191 Publication Model: Print Cited

Record details

CRISPR-Cas9-Mediated Gene Editing of MYB28 Genes Impair Glucoraphanin Accumulation of Brassica oleracea in the Field.

• Authors : Neequaye M; John Innes Centre, Norwich Research Park, Norwich, United Kingdom and Norwich Research Park, Norwich, United Kingdom.; Quadram Institute Bioscience, Norwich Research Park, Norwich, United Kingdom.

Subjects: CRISPR-Cas Systems*; Brassica/Brassica/Brassica/*genetics ; Brassica/Brassica/Brassica/*metabolism

• Source: The CRISPR journal [CRISPR J] 2021 Jun; Vol. 4 (3), pp. 416-426.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101738191 Publication Model: Print Cited

Record details

Optimizing Integration and Expression of Transgenic Bruton's Tyrosine Kinase for CRISPR-Cas9-Mediated Gene Editing of X-Linked Agammaglobulinemia.

• Authors : Gray DH; Molecular Biology Institute, University of California, Los Angeles, Los Angeles, California, USA; University of California, Los Angeles, Los Angeles, California, USA.

Subjects: CRISPR-Cas Systems* ; Genetic Therapy*; Agammaglobulinaemia Tyrosine Kinase/Agammaglobulinaemia Tyrosine Kinase/Agammaglobulinaemia Tyrosine Kinase/*genetics Bruton type agammaglobulinemia

• Source: The CRISPR journal [CRISPR J] 2021 Apr; Vol. 4 (2), pp. 191-206.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101738191 Publication Model: Print Cited

Record details

Vascular Tissue Engineering: Advanced Techniques and Gene Editing in Stem Cells for Graft Generation.

• Authors : Chen SG; Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hong Kong, SAR, China.; Ugwu F

Subjects: Gene Editing* ; Tissue Engineering*; Animals

• Source: Tissue engineering. Part B, Reviews [Tissue Eng Part B Rev] 2021 Feb; Vol. 27 (1), pp. 14-28. Date of Electronic Publication: 2020 Jul 27.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101466660 Publication Model: Print-Electronic

Record details

An Examination of Public Discourse on Human Gene Editing Using Natural Language Processing.

• Authors : Musser M; Georgetown University, Washington, DC, USA.

Subjects: Gene Editing* ; Natural Language Processing* ; Public Opinion*

• Source: The CRISPR journal [CRISPR J] 2020 Aug; Vol. 3 (4), pp. 237-247.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101738191 Publication Model: Print Cited

Record details

Promoter Orientation within an AAV-CRISPR Vector Affects Cas9 Expression and Gene Editing Efficiency.

• Authors : Fry LE; Nuffield Laboratory of Ophthalmology, Nuffield Department of Clinical Neurosciences and NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom; and Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.

Subjects: Gene Editing* ; Promoter Regions, Genetic*; CRISPR-Associated Protein 9/CRISPR-Associated Protein 9/CRISPR-Associated Protein 9/*genetics

• Source: The CRISPR journal [CRISPR J] 2020 Aug; Vol. 3 (4), pp. 276-283.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101738191 Publication Model: Print Cited

Record details